Arkolith/Insider Trading/ALLO/Form 4

Yoshiyama Annie

SVP, FinanceAllogene Therapeutics, Inc. (ALLO) · full profile →Form 4 · filed Apr 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2026Sell(S)10K$2.31$22K125K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001835208-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML